Kris MG - Search Results

1

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer.

Paik PK, Rudin CM, Pietanza MC, Brown A, Rizvi NA, Takebe N, Travis W, James L, Ginsberg MS, Juergens R, Markus S, Tyson L, Subzwari S, Kris MG, Krug LM. Paik PK, et al. Among authors: kris mg. Lung Cancer. 2011 Dec;74(3):481-5. doi: 10.1016/j.lungcan.2011.05.005. Epub 2011 May 26. Lung Cancer. 2011. PMID: 21620511 Free PMC article. Clinical Trial.

2

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.

Grant SC, Gralla RJ, Kris MG, Orazem J, Kitsis EA. Grant SC, et al. Among authors: kris mg. J Clin Oncol. 1992 Mar;10(3):484-98. doi: 10.1200/JCO.1992.10.3.484. J Clin Oncol. 1992. PMID: 1311028

3

Induction chemotherapy for non-small cell lung cancer with clinically evident mediastinal node metastases: the role of postoperative radiotherapy.

Armstrong JG, Martini N, Kris MG, Harrison LB. Armstrong JG, et al. Among authors: kris mg. Int J Radiat Oncol Biol Phys. 1992;23(3):605-13. doi: 10.1016/0360-3016(92)90018-d. Int J Radiat Oncol Biol Phys. 1992. PMID: 1319427 Clinical Trial.

4

A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancer.

Rosenstein M, Armstrong J, Kris M, Shank B, Scher H, Fass D, Harrison L, Fuks Z, Leibel S. Rosenstein M, et al. Int J Radiat Oncol Biol Phys. 1992;24(1):43-8. doi: 10.1016/0360-3016(92)91019-j. Int J Radiat Oncol Biol Phys. 1992. PMID: 1324901 Clinical Trial.

5

Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.

Kris MG, Tyson LB, Clark RA, Gralla RJ. Kris MG, et al. Cancer. 1992 Aug 15;70(4 Suppl):1012-6. Cancer. 1992. PMID: 1386282 Review.

6

Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide.

Rigas JR, Tong WP, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: kris mg. Cancer Res. 1992 Dec 1;52(23):6619-23. Cancer Res. 1992. PMID: 1423306 Clinical Trial.

7

Dose-ranging trial of zacopride: the emetic antiemetic?

Pisters KM, Kris MG, Tyson LB, Clark RA, Gralla RJ. Pisters KM, et al. Among authors: kris mg. J Natl Cancer Inst. 1992 May 6;84(9):717-8. doi: 10.1093/jnci/84.9.717. J Natl Cancer Inst. 1992. PMID: 1569606 Clinical Trial. No abstract available.

8

Limited small-cell lung cancer: do favorable short-term results predict ultimate outcome?

Armstrong J, Shank B, Scher H, Gaynor J, Martini N, Kutcher J, Kris M. Armstrong J, et al. Am J Clin Oncol. 1991 Aug;14(4):285-90. Am J Clin Oncol. 1991. PMID: 1650527

9

Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancer.

Rigas JR, Kris MG, Gralla RJ, Heelan RT, Marks LD. Rigas JR, et al. Among authors: kris mg. Invest New Drugs. 1991 May;9(2):187-90. doi: 10.1007/BF00175087. Invest New Drugs. 1991. PMID: 1651908 Clinical Trial.

10

Twice daily thoracic irradiation for limited small cell lung cancer.

Armstrong JG, Rosenstein MM, Kris MG, Shank BM, Scher HI, Fass DE, Harrison LB, Leibel SA, Fuks ZY. Armstrong JG, et al. Among authors: kris mg. Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1269-74. doi: 10.1016/0360-3016(91)90285-c. Int J Radiat Oncol Biol Phys. 1991. PMID: 1657842 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters